Skip to content

Bausch + Lomb E3097 BP

by Bausch & Lomb Incorporated

Bausch + Lomb E3097 BP is a corneal trephine manual instrument (FDA Class I; FDA product code HRH, Trephine, Manual, Ophthalmic) made by Bausch & Lomb Incorporated, listed in FDA GUDID since 30 Jul 2025 (UDI-DI 00757770435432), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00757770435432 UDI-DI Date30 Jul 2025ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
BASE PLUG
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile; sterilise before use (Moist Heat or Steam Sterilization)

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Bausch + Lomb
Generic name
Corneal trephine manual instrument
Model / Ref / Catalog
E3097 BP
Primary DI / UDI-DI
00757770435432
FDA product code
HRH
GMDN term
Corneal trephine manual instrument
Device class
Class I
Regulation number
886.4350
GUDID distribution status
In Commercial Distribution
Sterilisation method
Moist Heat or Steam Sterilization

Similar devices

Other devices filed under FDA product code HRH (Trephine, Manual, Ophthalmic).

Other devices from Bausch & Lomb Incorporated

See all devices from Bausch & Lomb Incorporated →

Properties

  • Sterilise before use
  • Prescription use
  • Premarket exempt
  • Lot / batch number
Other properties (11, all answered No)